Neostem (NBS) Reports Q2 EPS Loss of $0.13, Sales Fall Y/Y

Neostem (NYSE: NBS) reported Q2 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $23.77 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c